Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Guermazi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
La Tunisie Medicale|May 3, 2001
[Venous thromboembolic disease: risk factors and hemostatic anomalies]S Guermazi
Pathologie-Biologie|November 10, 2009
[Activated protein C resistance and factor V Leiden: clinical interest]S Guermazi, R Znazen
La Revue De Medecine Interne|September 26, 2008
[Resistance to curative treatment by unfractionned heparin]S Guermazi, R Znazen
Pathologie-Biologie|June 28, 2008
[Congenital protein S deficiencies; diagnostic difficulties]S Guermazi, J Conard
Archives De L'Institut Pasteur De Tunis|January 1, 1997
[Hematology laboratory]K Dellagi, S Guermazi
Thrombosis Research|May 1, 1997
Protein S deficiency and antibodies to protein S in patients with Behçet's diseaseS Guermazi, M Hamza, K Dellagi
Pathologie-Biologie|May 19, 2006
[Association of tow thrombotic risk factors: factor V Leiden and hyperhomocysteinemia. A case report]R Znazen, S Guermazi, M Karoui
Archives De L'Institut Pasteur De Tunis|January 1, 1997
[The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides]N Marrakchi, S Guermazi, M El Ayeb
Pathologie-Biologie|January 1, 1997
[Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time]S Guermazi, Y Gorgi, K Ayed, et al.
Pathologie-Biologie|September 24, 2005
[Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases]S Guermazi, J Conard, M M Samama, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
La Tunisie Medicale|May 3, 2001
[Venous thromboembolic disease: risk factors and hemostatic anomalies]S Guermazi
Pathologie-Biologie|November 10, 2009
[Activated protein C resistance and factor V Leiden: clinical interest]S Guermazi, R Znazen
La Revue De Medecine Interne|September 26, 2008
[Resistance to curative treatment by unfractionned heparin]S Guermazi, R Znazen
Pathologie-Biologie|June 28, 2008
[Congenital protein S deficiencies; diagnostic difficulties]S Guermazi, J Conard
Archives De L'Institut Pasteur De Tunis|January 1, 1997
[Hematology laboratory]K Dellagi, S Guermazi
Thrombosis Research|May 1, 1997
Protein S deficiency and antibodies to protein S in patients with Behçet's diseaseS Guermazi, M Hamza, K Dellagi
Pathologie-Biologie|May 19, 2006
[Association of tow thrombotic risk factors: factor V Leiden and hyperhomocysteinemia. A case report]R Znazen, S Guermazi, M Karoui
Archives De L'Institut Pasteur De Tunis|January 1, 1997
[The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides]N Marrakchi, S Guermazi, M El Ayeb
Pathologie-Biologie|January 1, 1997
[Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time]S Guermazi, Y Gorgi, K Ayed, et al.
Pathologie-Biologie|September 24, 2005
[Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases]S Guermazi, J Conard, M M Samama, et al.
Pageof 4